» Articles » PMID: 16973808

Raised Plasma N-terminal Pro-B-type Natriuretic Peptide Concentrations Predict Mortality and Cardiac Disease in End-stage Renal Disease

Overview
Journal Heart
Date 2006 Sep 16
PMID 16973808
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Do Natriuretic Peptide Measurements Provide Insights into Management of End-Stage Renal Disease Patients Undergoing Dialysis?.

Chaikijurajai T, Choles H, Tang W Curr Heart Fail Rep. 2020; 17(6):449-456.

PMID: 32939671 PMC: 7686100. DOI: 10.1007/s11897-020-00488-6.


Prognostic utility of NT-proBNP greater than 70,000 pg/mL in patients with end stage renal disease.

Perez-Downes J, Palacio C, Ibrahim S, Shelley P, Miller A, Reddy P J Geriatr Cardiol. 2018; 15(7):476-478.

PMID: 30364747 PMC: 6198270. DOI: 10.11909/j.issn.1671-5411.2018.07.002.


Inverse relationship of bone mineral density and serum level of N-terminal pro-B-type natriuretic peptide in peritoneal dialysis patients.

Wang C, Tsai J, Lai Y, Lin Y, Kuo C, Hsu B Tzu Chi Med J. 2017; 28(2):68-72.

PMID: 28757725 PMC: 5442895. DOI: 10.1016/j.tcmj.2016.03.003.


B-type natriuretic peptide and prognosis of end-stage renal disease: a meta-analysis.

Cheng Y, Yao F, Liu L, Tang K, Lin X, Li W PLoS One. 2013; 8(11):e79302.

PMID: 24236118 PMC: 3827377. DOI: 10.1371/journal.pone.0079302.


Association between N-terminal pro-brain natriuretic peptide and acute ischemic stroke in patients on chronic hemodialysis.

Kim Y, Shin S, Ihm S, Park C, Kim H, Kim Y Int Urol Nephrol. 2009; 42(2):537-43.

PMID: 20039125 DOI: 10.1007/s11255-009-9689-8.

References
1.
Loke I, Squire I, Davies J, Ng L . Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate. Eur J Heart Fail. 2003; 5(5):599-606. DOI: 10.1016/s1388-9842(03)00108-9. View

2.
Apple F, Murakami M, Pearce L, Herzog C . Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem. 2004; 50(12):2279-85. DOI: 10.1373/clinchem.2004.035741. View

3.
Sharma R, Pellerin D, Gaze D, Shah J, Streather C, Collinson P . Dobutamine stress echocardiography and cardiac troponin T for the detection of significant coronary artery disease and predicting outcome in renal transplant candidates. Eur J Echocardiogr. 2005; 6(5):327-35. DOI: 10.1016/j.euje.2005.04.011. View

4.
deFilippi C, Fink J, Nass C, Chen H, Christenson R . N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis. Am J Kidney Dis. 2005; 46(1):35-44. DOI: 10.1053/j.ajkd.2005.04.007. View

5.
Januzzi Jr J, Camargo C, Anwaruddin S, Baggish A, Chen A, Krauser D . The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol. 2005; 95(8):948-54. DOI: 10.1016/j.amjcard.2004.12.032. View